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Soft tissues healing at immediate transmucosal implants placed into 
molar extraction sites associated with buccal self-contained 
dehiscences.  
A 12-month controlled clinical trial 
 
Introduction 
A reduced number of surgical interventions, a shorter treatment time, an ideal three-
dimensional implant placement and an optimal outcome of soft tissue esthetics have been 
listed as potential advantages of immediate implant placement into fresh extraction 
sockets (Chen et al. 2004). On the other hand, the site morphology, the presence of active 
periapical pathology, the absence of keratinized tissue or a thin tissue biotype and the lack 
of complete soft tissue closure over the extraction socket were reported to adversely affect 
the outcomes of immediate implant placement (Hämmerle et al. 2004). 
Outcomes from experimental studies indicated that buccal alveolar structures are lost 
irrespective of the immediate placement of an implant at time of tooth extraction (Araujo & 
Lindhe 2005, Araujo et al. 2005). Furthermore, a marked difference in the reduction of the 
width of the socket walls after tooth extraction and immediate implant placement was 
observed depending on the anatomic location (i.e. premolar vs. molar sites) (Araujo et al. 
2006). In that animal experiment, the reduction of the width of the socket walls was more 
pronounced at the thicker buccal wall of molar sites compared with that of the thinner wall 
of premolar sites (Araujo et al. 2006). Although the peri-implant marginal defect was 
resolved after 3 months, the bone modeling process in both areas (i.e. premolar and molar 
sites) was accompanied by a substantial reduction of the dimensions of both the buccal 
and the lingual socket walls.  
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Additional experimental findings indicated that the rate of healing and degree of resolution 
of marginal peri-implant bone defects after implant installation were dependent on whether 
or not the defect was prepared in a healed alveolar site or presented as a gap of a fresh 
extraction socket (Botticelli et al. 2006). Findings from that experiment revealed that, after 
4 months, most defects prepared in a healed alveolar ridge were completely resolved, 
whereas healing of fresh extraction sockets was incomplete (Botticelli et al. 2006). 
Evidence for the clinical effectiveness of immediate implant placement following extraction 
of maxillary and mandibular molars is limited (Schwartz-Arad et al. 2000, Artzi et al. 2003, 
Cafiero et al. 2008). Outcomes from a case series report (Schwartz-Arad et al. 2000) 
highlighted a marked difference between the 5-year cumulative survival rate of mandibular 
(e.g. 92%) versus maxillary (e.g. 82%) molars, respectively. Outcomes from a multicenter 
prospective cohort study demonstrated that the use of tapered-effect implants for the 
immediate replacement of maxillary and mandibular molars lost because of caries, 
endodontic failure or vertical root fracture represented a predictable treatment after an 
observation period of 12 months (Cafiero et al. 2008). In that study, no significant 
difference with respect to survival rate was observed comparing maxillary with mandibular 
molars after 12 months (Cafiero et al. 2008). It should be noted that in that study (Cafiero 
et al. 2008) tapered-effect implants were installed into fresh extraction sockets with intact 
alveolar bone walls. 
Hence, the aim of this prospective controlled clinical trial was to compare soft tissue 
healing at immediate transmucosal implants placed in molar extraction sites associated 
with buccal self-contained dehiscences with that of implants placed in healed sites without 
buccal dehiscences.   
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Materials and methods 
Sampling  
A power calculation was carried out to determine the sample size using the implant as the 
statistical unit. Differences in pocket probing depth (PPD) between test and control 
implants were set as the primary outcome. To detect with 80% power a statistically 
significant difference for the primary outcome of δ=1.5 mm with a standard deviation of σ= 
2.0 mm, a sample size of 15 test and 15 control implants was calculated.              
 
Experimental design 
The study was designed as a prospective controlled clinical trial of 12 months duration. 
Test implants were immediately placed in molar extraction sockets associated with a 
buccal bone defect of ≥ 3 mm in height (Figure 1 A-B) and width (Figure 1 C-D), 
respectively. The buccal bone defects were treated according to the principles of Guided 
Bone Regeneration (GBR) using deproteinized bovine bone mineral granules (BioOss®, 
Geistlich Biomaterials, Wolhusen, LU, Switzerland) and a resorbable collagen membrane 
(BioGide®, Geistlich Biomaterials, Wolhusen, LU, Switzerland).  
Control implants were placed in molar sites without buccal bone defects following tooth 
extraction and a 6-month healing period. 
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Figure 1. Characterization of the buccal bone dehiscence of ≥ 3 mm in apico-coronal 
height (A-B) and mesio-distal width (C-D). 
A-B:  Vertical distance from the SLA-turned transition on the implant surface (A) 
  to the most coronal point of the mid-buccal alveolar crest (B). 
C-D:  Horizontal distance of the buccal bone dehiscence assessed from the mesio-
  buccal alveolar bone height (C) to the disto-buccal alveolar bone height (D). 
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Subject population 
A total of 30 tapered implants of the Straumann® Dental Implant System (Straumann 
Institute, Basel, Switzerland) with a sandblasted and acid-etched (SLA) surface, an 
endosseous diameter of 4.8 mm, a shoulder diameter of 6.5 mm and a height of the turned 
neck 1.8 mm were installed in 30 subjects (Figure 2). All subjects were enrolled from the 
Department of Periodontology, University of Naples “Federico II”, Naples, Italy.  
 
Figure 2. Tapered-effect (TE) implant of the Straumann® Dental Implant System 
(Straumann Institut AG, Basel, Switzerland) with an endosseous diameter of 4.8 mm and a 
shoulder diameter of 6.5 mm. The height of the supracrestal turned neck from the implant 
shoulder to the sand-blasted and acid-etched (SLA) implant surface amounts to 1.8 mm. 
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Subject selection  
Inclusion criteria 
• Age ≥ 18 years 
• Absence of relevant medical conditions contraindicating surgical interventions 
• Presence of a mandibular or maxillary molar to be extracted because of an 
endodontic failure, caries or vertical root fracture 
• Presence of a tooth mesially and distally to the extraction site 
• Full-mouth plaque score (FMPS) ≤ 25 % at baseline 
• Full-mouth bleeding score (FMBS) ≤ 25 % at baseline 
• Test group: Presence of a buccal bone dehiscence of ≥ 3 mm in apico-coronal 
height  and in mesio-distal width after implant insertion (Figure 1 A-B and C-D, 
respectively) 
• Control group: Presence of a buccal bone wall of ≥ 1 mm thickness at the most 
coronal part of the SLA implant surface  
• Presence of ≥ 2 mm of keratinized tissue to allow soft tissue manipulation 
• Presence of sufficient residual alveolar bone volume to achieve primary implant 
stability 
• Signed informed consent 
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Exclusion criteria  
• Mandibular or maxillary molars to be extracted for periodontal reasons (e.g. 
furcation involvement, angular bony defects) 
• Pregnant or lactating females 
• Cigarette, pipe or cigar smoking 
• Full-mouth plaque score (FMPS) > 25 % at baseline 
• Full-mouth bleeding score (FMBS) > 25 % at baseline 
• Untreated periodontal conditions 
• Clinical and/or radiographic signs of periapical pathology contraindicating 
immediate implant placement 
• Previously augmented recipient sites for control implants 
• Maxillary and mandibular third molars 
• Failure to sign informed consent 
 
The study protocol was submitted to and approved by the Ethical Committee of the 
University  “ Federico II ”, Naples, Italy. Written informed consent was obtained and the 
study was conducted according to the principles of the Declaration of Helsinki on 
experimentation involving human subjects.   
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Experimental procedures 
Clinical parameters 
The following parameters were recorded at baseline and/or at the 12-month follow-up 
around teeth or implants: 
• Full-Mouth Plaque Score (FMPS) at six sites per tooth  (i.e. disto-buccal, buccal, 
mesio-buccal, mesio-oral, oral, disto-oral) 
• Full-Mouth Bleeding Score (FMBS) at six sites per tooth  (i. e. disto-buccal, buccal, 
mesio-buccal, mesio-oral, oral, disto-oral) 
• Pocket Probing Depth (PPD) at four sites (i.e. distal, mid-buccal, mid-oral, mesial) 
• Clinical Attachment Level (CAL) at four sites (i.e. distal, mid-buccal, mid-oral, 
mesial) 
Surgical procedures 
Molar extraction and implant placement were performed simultaneously (Figure 3). 
 
Figure 3. Buccal view after extraction of tooth 16 and immediate implant placement in an 
extraction site with self-contained buccal defect. The transition line of the SLA-turned 
implant surface is at the level of the mesio-distal alveolar crest (see Fig. 1). 
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 A full-thickness muco-periosteal flap was elevated extending to at least one tooth in 
mesial and distal direction. Following separation of the roots and careful tooth extraction, 
preparation of the implant bed in the area of the interradicular septum and implant 
placement were carried out. Tapered-effect (TE) implants of the Straumann® Dental 
Implant System (Straumann AG, Basel, Switzerland) with a sandblasted and acid-etched 
(SLA) surface, an endosseous diameter of 4.8 mm and a shoulder diameter of 6.5 mm 
were placed according to manufacturer’s instructions. The turned neck portion of the 
implant (i.e. 1.8 mm) was positioned at the level of the alveolar crest in both test and 
control implants. Primary stability of the test implants was achieved in the remaining apical 
portion of the interradicular septum. The marginal gap between the implants and the inner 
walls of the extraction sockets as well as the buccal bone dehiscences of the test implants 
were regenerated by the use of a bioresorbable membrane supported by a bone 
substitute. Deproteinized bovine bone mineral particles with a size of 0.25 to 1.00 mm 
(BioOss®, Geistlich Biomaterials, Wolhusen, LU, Switzerland) were placed into the defect, 
followed by the punch and adaptation of a collagen membrane of porcine origin (BioGide®, 
Geistlich Biomaterials, Wolhusen, LU, Switzerland) around the neck of the implant. The 
barrier membrane extended 3-4 mm beyond the borders of the bone defect. After insertion 
of a non-beveled healing cap, the buccal and lingual/palatal flaps were repositioned and 
sutured around the neck of the implant using 4-0 non-resorbable sutures (Ethibond Excel, 
Ethicon, Johnson & Johnson, NJ, USA) aiming at a transmucosal wound healing.  
Intrasurgical measurements (Test group)  
The following intrasurgical measurements were recorded immediately after tooth extraction 
and implant placement (Figure 4): 
• IS-BD:  Vertical distance from the implant shoulder (IS) to the most apical 
extension of the bone defect (BD) 
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• C-BD: Vertical distance from the most coronal extension of the alveolar crest (C) to 
the most apical extension of the bone defect (BD) 
• C-I: Horizontal distance from the height of the alveolar crest (C) to the implant 
surface (I) 
• A-B: Height of the buccal dehiscence measured from the SLA-turned transition line 
(A) to the most coronal extension of the mid-buccal bone crest (B) 
• C-D: Width of the buccal dehiscence measured from the mesio-buccal bone crest 
(C) to the disto-buccal bone crest (D) 
 
Figure 4. Bucco-oral schematic illustration of the marginal peri-implant defects at time of 
placement of test implants. 
 
C-I: Horizontal distance of the marginal defect from the alveolar crest (C) to the implant (I) 
surface. 
 
IS-BD: Vertical distance from the implant shoulder (IS) to the bottom of the marginal bone 
defect (BD). 
 
C-BD: Vertical distance from the alveolar crest (C) to the bottom of the marginal bone 
defect (BD). 
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Post-surgical instructions and infection control 
Post-operative pain was controlled with ibuprofen (e.g. 600 mg immediately before the 
surgical intervention and after 4 hours). In cases of contraindications to NSAIDs (e.g. 
ulcer, gastritis) acetaminophen (e.g. 500 mg immediately before the surgical intervention 
and after 6 hours) was prescribed. To minimize postoperative swelling, all subjects were 
instructed to intermittently apply an ice bag for the first 2 hours after the surgical 
intervention. 
To prevent wound infection, all subjects received systemic antibiotics (e.g. amoxicillin with 
clavulanic acid) for 5 days postsurgically. Moreover, subjects were instructed to rinse twice 
daily with 0.12% chlorhexidine digluconate and to use modified oral hygiene procedures in 
the treated area for the first 4 post-operative weeks. 
Modified oral hygiene instructions for the treated area were given to the subjects (Heitz et 
al. 2004). Starting on the third day after surgery and up to the fourth postsurgical week, 
subjects were advised to gently wipe the treated area by means of a very soft toothbrush. 
The toothbrush was soaked in chlorhexidine solution and used to wipe the peri-implant 
area with light vertical strokes. No interdental cleaning in the treated area with brushes, 
floss, or toothpicks by the patient was allowed in the first four weeks. Teeth not adjacent to 
the surgical site were cleaned using normal oral hygiene practices. 
Sutures were removed at the two-week post surgical appointment. Post-surgical 
appointments consisting of professional supragingival tooth cleaning with rubber cup and 
chlorhexidine gel as well as interproximal cleaning with superfloss and chlorhexidine gel 
were performed 2, 4 and 6 weeks after implant installation. Four weeks after implant 
installation, subjects were instructed to resume normal oral hygiene procedures including 
full-mouth interproximal cleaning and to discontinue chlorhexidine mouth rinsing. 
 
 12 
 
Delivery of fixed single-unit crowns 
A provisional acrylic single-unit crown was cemented 3 months after implant placement. 
After a period of 30 ± 10 days, a definitive prosthetic reconstruction by means of a 
porcelain-fused-to-metal single unit crown was cemented. 
 
 
Data analysis 
The heterogeneity between test and control groups was verified using the Pearson χ2  test. 
A χ2 value  < 0.05 was accepted to identify a statistically significant difference. 
Because no differences were observed between test and control subjects, the implant was 
used as the statistical unit.  
In each group all variables were expressed in millimeters with the exception of FMPS and 
FMBS scores that were expressed in percentages. Descriptive statistics (e.g. means ± 
standard deviation) were used to present the subject population. 
The comparisons of the variables between test and control groups at the 12-month follow-
up were performed using the unpaired t-test. A p value < 0.05 was accepted to identify a 
statistically significant difference. 
The data analysis was performed using a commercially available statistical software 
package (NCSS-PASS®, Number Cruncher Statistical Systems, Kaysville, USA).  
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Results 
Demographic data 
The detailed characteristics of the subject population at baseline are presented in Table 1. 
After screening, a total of 30 subjects fulfilling the inclusion criteria were enrolled and 
allocated to either the test or control group. No statistically significant differences (χ2 > 
0.05) were observed with respect to age, gender, FMPS and FMBS comparing test with 
control subjects. 
 
Table 1. Characteristics of the subject population at time of implant installation. 
 
 
 
 
 
 
 
FMPS: Full Mouth Plaque Score 
FMBS: Full Mouth Bleeding Score 
      
 A  χ2 value < 0.05 was accepted to identify a statistically significant difference. 
 
NS: Not statitstically significant different 
 
 
 
 Test Group  
N=15 
Control Group  
N=15 
χ
2
 
 
Age (years ± SD) 
 
Gender  (%)  
                             
 
FMPS  (% ± SD) 
 
FMBS  (% ± SD) 
 
48.1 ± 16.5 
 
7 males  (46.6%) 
8 females  (53.4%) 
 
10.3 ± 5.0 
 
8.7 ± 5.1 
 
 
 
49.5 ± 15.3 
 
9 males  (66.7%) 
6 females  (33.3%) 
 
           16.6 ± 5.2 
 
12.1 ± 3.6 
 
 
 
0.12 (NS) 
 
3.69 (NS) 
 
 
0.06 (NS) 
 
0.06 (NS) 
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Table 2 summarizes the maxillary and mandibular implant locations. No statistically 
significant differences (χ2 > 0.05) were observed with respect to implant location when 
comparing test with control subjects. 
 
Table 2. Distribution of test and control implants in the maxilla and mandible. 
 
Location of implants 
 
Test Group  
N=15 
Control Group  
N=15 
 
χ
2
 
Right  maxillary 1st  molar (16) 5 3 0.71 (NS) 
Left    maxillary 1st molar ( 26) 0 0 - 
Left   mandibular 1st molar (36) 3 4 0.83 (NS) 
Right  mandibular 1st  molar (46) 0 0 - 
Right  maxillary 2st  molar (17) 0 0 - 
Left    maxillary 2st molar ( 27) 3 4 0.83  (NS) 
Left   mandibular 2st molar (37) 4 4 1 (NS) 
Right  mandibular 2st  molar (47) 0 0 - 
A χ2 value < 0.05 was accepted to identify a statistically significant difference. 
 
NS: Not statistically significant different 
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Surgical outcomes 
All subjects completed the 12-month follow-up examination. No implants were lost during 
this observation period yielding a one-year survival rate of 100%. 
No post-surgical wound healing complications (i.e. bacterial infections) were observed. 
However, on the palatal aspects of all test implants placed in the maxillary first and second 
molar area an exposure of the collagen membrane was present at time of flap suturing due 
to the impossibility of soft tissue mobilisation. 
Table 3 illustrates the reasons for molar extraction. The most frequent cause was root 
fracture (i.e. 60 %) followed by endodontic failures (i.e. 26.6 %) and  caries (i.e. 13.4 %). 
 
Table 3. Reasons for molar tooth extraction. 
 
Reasons for molar tooth 
extraction 
(%) 
Root fracture 60 
Endodontic failure 26.6 
Caries 13.4 
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Table 4 summarizes the linear measurements around test implants at time of installation. 
The vertical distance from the implant shoulder (IS) to the most apical extension of the 
bone defect (BD) amounted to 10.8 ± 1.5 mm at the mesial, 10.5 ± 1.8 mm at the buccal, 
9.8 ± 2.3 mm at the distal and 10.7 ± 1.9 mm at the oral site, respectively. The vertical 
distance from the most coronal extension of the alveolar crest (C) to the most apical 
extension of the bone defect (BD) was 9.0 ± 1.4  mm at the mesial, 2.9 ± 1.5 mm at the 
buccal, 7.7 ± 2.3 mm at the distal and 9.2 ± 1.9 mm at the oral site, respectively. The 
horizontal distance from the most coronal height of the alveolar crest (C) to the implant 
surface (I) was 1.9 ± 1.1 mm at the mesial, 1.7 ± 1.1 mm at the buccal, 2.0 ± 1.0 mm at the 
distal and 3.8 ± 0.8 mm at the oral site, respectively. 
 
Table 4.  Mean ± standard deviation (SD) of intrasurgical linear measurements assessed 
at four sites (i.e. mesial, buccal, distal, oral) around each test implant. 
 
IS-BD: Vertical distance from the implant shoulder (IS) to the most apical extension of the 
 bone  defect (BD). 
C-BD: Vertical distance from the most coronal extension of the alveolar crest (C) to the 
 most apical extension of the bone defect (BD). 
 C-I: Horizontal width from the mid-buccal height of the alveolar crest (C) to the implant 
 surface (I) 
 
 
 
 
 
 
 
 Mesial Buccal Distal Oral 
IS-BD (mm) 10.8 ± 1.5 10.5 ± 1.8 9.8 ± 2.3 10.7 ± 1.9 
C-BD (mm) 9.0 ± 1.4 2.9 ± 1.5 7.7 ± 2.3 9.2 ± 1.9 
C-I (mm) 1.9 ± 1.1 1.7 ± 1.1 2.0 ± 1.0 3.8 ± 0.8 
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Table 5 shows that the vertical distance (i.e. A-B) of the buccal bone dehiscence of test 
implants amounted to 5.2 ± 2.6 mm whereas the horizontal dimension (C-D) was 7.9  ± 1.7 
mm. 
 
Table 5.  Mean vertical (A-B) and horizontal (C-D) linear measurements ± standard 
deviation (SD) of the buccal self-contained bone dehiscences at test implants. 
 
 Height (A-B) 
(mm ± SD) 
          Width (C-D) 
(mm ± SD) 
Mean ± SD 5.2 ± 2.6 7.9 ± 1.7 
 
A-B:  Height of the buccal dehiscence measured from the SLA-turned transition (A) to the 
 most coronal extension of the mid-buccal alveolar bone crest (B) 
 C-D:  Width of the buccal dehiscence measured from the mesio-buccal alveolar bone 
 crest (C)  to  the disto-buccal alveolar bone crest (D) 
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Table 6 summarizes the assessments of pocket probing depth (PPD) and clinical 
attachment level (CAL) at four sites (i.e. mesial, distal, buccal, oral) around test and control 
implants at the 12-month follow-up. The PPD of test implants was 4.13 ± 1.13 mm at the 
mesial, 3.7± 1.0 mm at the buccal, 4.13 ± 0.83 mm at the distal and 4.33 ± 0.98 mm at the 
oral site, respectively. The corresponding values for the control implants were 3.13 ± 0.52 
mm at the mesial, 2.2 ± 0.8 mm at the buccal, 3.00 ± 0.65 mm at the distal and 3.20 ± 0.56 
mm at the oral site, respectively. 
The CAL values recorded around test implants were 3.80 ± 0.78 mm at the mesial, 4.7 ± 
1.0 mm at the buccal, 4.80 ± 0.94 mm at the distal and 4.87 ± 0.92 mm at the oral site, 
respectively. The corresponding values for the control implants were 3.33 ± 0.72 mm at 
the mesial, 2.4 ± 1.0 mm at the buccal, 3.27 ± 0.70 mm at the distal and 3.33 ± 0.72 mm at 
the oral site, respectively. 
Statistically significant differences (p < 0.05) were observed with respect to both PPD  and  
CAL when comparing test and control implants at the 12-month follow-up. 
 
 
Table 6.  Comparison of mean pocket probing depths (PPD) ± standard deviation (SD) 
and mean clinical attachment levels (CAL) ± standard deviation (SD) assessed at four 
sites (i.e. mesial, buccal, distal, oral) at the 12-month follow-up between test and control 
implants.  
 
 
 
 
Mean PPD ± SD (mm) 
 
Mean CAL ± SD (mm) 
 
 
 
 
Test implants 
 
 
Control implants 
 
 
p-value 
 
      
      Mesial        Buccal          Distal           Oral 
 
 
   4.13±1.13     3.7±1.0     4.13±0.83    4.33±0.98 
 
 
   3.13±0.52     2.2±0.8     3.00±0.65    3.20±0.56 
 
 
     p = 0.01    p <0.001   p < 0.001   p < 0.001    
      
      Mesial        Buccal           Distal             Oral 
 
 
   3.80±0.78     4.7±1.0      4.80±0.94     4.87±0.92 
 
 
   3.33±0.72     2.4±1.0      3.27±0.70     3.33±0.72 
 
 
    p = 0.01   p < 0.001        p < 0.001     p < 0.001 
A p value < 0.05 was accepted to identify a statistically significant difference. 
 
PPD:  Pocket Probing Depth 
CAL: Clinical attachment level 
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Discussion 
 
The findings of this 12-month controlled clinical study demonstrated that wound healing at 
immediate implants placed into molar extraction sites associated with buccal self-
contained dehiscences was inferior compared with that around implants placed in healed 
bone resulting in lack of complete osseointegration. Although multirooted teeth with bone 
loss due to periodontitis (e.g. vertical and furcation defects) had been excluded from the 
present study, immediate implant placement in molar sites was always accompanied by 
self-contained marginal defects at all aspects (i.e. mesial, distal, oral and buccal). 
Outcomes from animal studies indicated that 1-2.25 mm wide self-contained peri-implant 
marginal defects without vertical bone dehiscence became filled with newly formed bone 
after a 4-month healing period without the use of grafting materials (Botticelli et al. 2003, 
2004). Further experimental evidence demonstrated that the rate of healing and degree of 
resolution of self-contained marginal defects after implant installation were dependent on 
whether or not the defect was prepared in a healed alveolar site or presented as a void of 
a fresh extraction socket (Botticelli et al. 2006). Findings from that experiment (Botticelli et 
al. 2006) showed that, after 4 months, most defects prepared in healed bone were 
completely resolved, whereas healing of fresh extraction sockets was incomplete.  
Clinical outcomes of a 12-month prospective cohort study showed that immediate 
transmucosal implant placement into extraction sockets with intact height of the alveolar 
walls represented a predictable treatment for the replacement of mandibular and maxillary 
molars lost because of reasons other than periodontitis (Cafiero et al. 2008). In that study 
(Cafiero et al. 2008), the residual self-contained defects present after molar extraction and 
immediate implant placement displayed intact buccal alveolar walls. The values of the 
residual marginal peri-implant defects recorded at the mesial, distal and oral aspects in the 
study by Cafiero et al. (2008) were comparable with those of the present study. A 
substantial difference, however, was observed at buccal aspects with respect to the 
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distance from the implant shoulder to the bottom of the defect (e.g IS-BD). The mean 
vertical distance IS-BD at buccal aspects amounted to 4.9 ± 4.6 mm in the study by 
Cafiero et al.  (2008) whereas it was 10.5 ± 1.8 mm in the present study.  
The presence of self-contained bone defects at the buccal aspect at time of immediate 
implant placement represented an additional challenge in the present study. Clinically, the 
buccal bone crest was, after molar extraction and immediate implant placement, at a more 
apical level compared with the mesial, distal and oral aspects. Furthermore, the mean 
width of the buccal bone dehiscence (e.g. 7.9±1.7 mm) present after molar extraction 
exceeded the corresponding mean height (e.g. 5.2±2.6 mm) in the present study. This is in 
contrast to the measurements of buccal bone dehiscences observed after extraction of 
single-rooted teeth and immediate-delayed implant placement (Nemcovsky et al. 2000). In 
that study (Nemcovsky et al. 2000) the mean height of the buccal bone dehiscence (e.g. 
6.7± 2.2mm) exceeded the mean width (e.g 4.3±0.9 mm). Moreover, Nemcovsky and Artzi 
(2002) reported significant improvements in the reduction of buccal defect height and width 
after single-tooth extraction and immediate implant placement in conjunction with 
submerged wound healing. Hence, tooth morphology (e.g. single- versus multi-rooted 
teeth) yields different shapes of buccal dehiscences after tooth extraction, thereby 
influencing the ratio between height and width of the buccal marginal defect. This may be 
relevant for complete resolution of the marginal defect following immediate implant 
placement in conjunction with bone regenerative procedures.  
Outcomes from an experimental study in the dog showed that the configuration of the 
marginal portion of artificial defects created in healed bone played an important role in 
terms of wound healing (Botticelli et al. 2004). Buccally open peri-implant defects of 
varying dimensions healed with less new bone formation compared with the other aspects 
of the same defect (e.g. mesial, distal and oral). The authors of that study (Botticelli et al. 
2004) postulated that the observed compromised bone fill at buccal aspects was related 
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to an inadequate space maintaining effect provided by the resorbable collagen membrane 
without the concomitant use of autogenous bone or a bone substitute. Thus, the 
resorbable membrane used in that animal experiment (Botticelli et al. 2004) may have 
collapsed into the buccal defect during wound healing, thereby reducing space available 
for new bone formation at this specific site of the defect. In the present clinical study, the 
same resorbable collagen membrane as in the above mentioned animal experiment 
(Botticelli et al. 2004) was used in conjunction with immediate implant placement. 
However, in the present study the resorbable membrane had been adapted around the 
neck of the implant and had always been supported by deproteinized bovine bone 
particles covering the exposed buccal implant surface as well as the residual marginal 
gaps. Although a membrane support was provided, a compromised wound healing 
accompanied by incomplete osseointegratioin was observed when comparing test with 
control implants in the present study. Outcomes from previous experimental studies in 
dogs, however, showed that buccal peri-implant defects protected by a rigid expanded 
polytetrafluorethylene (e-PTFE) membrane with or without the use of bone grafts were 
completely resolved  after 12-16 weeks of healing (Lekholm et al. 1993, Becker et al. 
1995).  
In conclusion, significant differences in clinical parameters (e.g. PPD and CAL) at all 
aspects (i.e. mesial, distal, oral, buccal) were recorded after 12 months when comparing 
immediate transmucosal implants placed into molar extraction sites associated with 
buccal self-contained dehiscences with control implants placed in healed bone. Hence, 
wound healing after immediate implant placement in molar extraction sites was inferior 
compared with that of control implants and resulted in lack of complete osseointegration. 
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